SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Ingrevia commissions new Diketene derivatives facility at Gajraula

17 Feb 2022 Evaluate

Jubilant Ingrevia has commissioned new Diketene derivatives facility at its manufacturing site in North India at Gajraula, Uttar Pradesh. The company for many years has niche expertise in using Ketene chemistry technology. Using the Ketene chemistry capability, the company has developed a range of Diketene Derivatives. The newly commissioned facility marks the entry of the company into the fast growing Diketene business portfolio. This reiterates Jubilant Ingrevia’a commitment towards growth through its integrated business model, by providing value added products & innovative solutions to its customers.

The commissioned facility has about 7,000 TPA capacity to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate and Ter-Butyl Acetoacetate). The Company’s long-standing association with leading customers in Pharmaceuticals, Agrochemicals and other industries and its advance efforts to get product approval from customers, will help in utilizing a major portion of the capacity of this new facility in the coming months. Jubilant Ingrevia undertakes to commission future phases of Diketene Derivatives as per plan.

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.

Jubilant Ingrevia Share Price

735.50 36.20 (5.18%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3739.05
Tata Chemicals 707.80
SRF 2541.95
Pidilite Inds. 1402.25
Deepak Nitrite 1731.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×